These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28484914)

  • 1. Further evidence on EQ-5D-5L preference inversion: a Brazil/U.S. collaboration.
    Craig BM; Monteiro AL; Herdman M; Santos M
    Qual Life Res; 2017 Sep; 26(9):2489-2496. PubMed ID: 28484914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do health preferences contradict ordering of EQ-5D labels?
    Craig BM; Pickard AS; Rand-Hendriksen K
    Qual Life Res; 2015 Jul; 24(7):1759-65. PubMed ID: 25519940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.
    Rencz F; Brodszky V; Gulácsi L; Golicki D; Ruzsa G; Pickard AS; Law EH; Péntek M
    Value Health; 2020 Sep; 23(9):1235-1245. PubMed ID: 32940242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the causal and effect nature of EQ-5D dimensions: an application of confirmatory tetrad analysis and confirmatory factor analysis.
    Gamst-Klaussen T; Gudex C; Olsen JA
    Health Qual Life Outcomes; 2018 Jul; 16(1):153. PubMed ID: 30064432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.
    Shafie AA; Vasan Thakumar A; Lim CJ; Luo N
    Qual Life Res; 2019 Jan; 28(1):153-162. PubMed ID: 30317426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice Defines QALYs: A US Valuation of the EQ-5D-5L.
    Craig BM; Rand K
    Med Care; 2018 Jun; 56(6):529-536. PubMed ID: 29668646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the measurement equivalence of EQ-5D-5L across different modes of administration.
    Mulhern B; O'Gorman H; Rotherham N; Brazier J
    Health Qual Life Outcomes; 2015 Nov; 13():191. PubMed ID: 26612336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
    Yfantopoulos J; Chantzaras A; Kontodimas S
    Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
    Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
    Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
    Feng Y; Herdman M; van Nooten F; Cleeland C; Parkin D; Ikeda S; Igarashi A; Devlin NJ
    Qual Life Res; 2017 Aug; 26(8):2067-2078. PubMed ID: 28343350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation, validity and reliability of the British Sign Language (BSL) version of the EQ-5D-5L.
    Rogers KD; Pilling M; Davies L; Belk R; Nassimi-Green C; Young A
    Qual Life Res; 2016 Jul; 25(7):1825-34. PubMed ID: 26887955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.
    Crick K; Al Sayah F; Ohinmaa A; Johnson JA
    Qual Life Res; 2018 Jun; 27(6):1625-1633. PubMed ID: 29516342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.
    Jiang J; Hong Y; Zhang T; Yang Z; Lin T; Liang Z; Lu P; Liu L; Wang B; Xu Y; Luo N
    Qual Life Res; 2021 Jul; 30(7):2045-2060. PubMed ID: 33821418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys.
    Martí-Pastor M; Pont A; Ávila M; Garin O; Vilagut G; Forero CG; Pardo Y; Tresserras R; Medina-Bustos A; Garcia-Codina O; Cabasés J; Rajmil L; Alonso J; Ferrer M
    Popul Health Metr; 2018 Aug; 16(1):14. PubMed ID: 30115092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.